These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37302448)

  • 1. A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care.
    Khasawneh M; Craig OF; Gracie DJ; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3397-3404.e1. PubMed ID: 37302448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Black CJ; Craig O; Gracie DJ; Ford AC
    Gut; 2021 Jun; 70(6):1110-1116. PubMed ID: 32973070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
    Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome in children with chronic gastrointestinal symptoms in primary care.
    Hogervorst EM; Ganzevoort IN; Berger MY; Holtman GA
    Fam Pract; 2024 Jun; 41(3):292-298. PubMed ID: 37392047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
    Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.